Amanote Research

Amanote Research

    RegisterSign In

BGP‐15: A Potential Therapeutic Agent for Critical Illness Myopathy

Acta Physiologica - United Kingdom
doi 10.1111/apha.13441
Full Text
Open PDF
Abstract

Available in full text

Categories
Physiology
Date

January 20, 2020

Authors
Takashi Yamada
Publisher

Wiley


Related search

Clinical Review: Critical Illness Polyneuropathy and Myopathy

Critical Care
Critical CareIntensive Care Medicine
2008English

Diagnostic Tools for Critical Illness Myopathy in a Patient After Liver Transplantation: A Case Report

HPB
HepatologyGastroenterology
2018English

Critical Illness Myopathy Is Frequent: Accompanying Neuropathy Protracts ICU Discharge

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2010English

Delonix Regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection

PLoS ONE
Multidisciplinary
2016English

Iron Metabolism: An Emerging Therapeutic Target in Critical Illness

Critical Care
Critical CareIntensive Care Medicine
2019English

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

Growth Differentiating Factor-15 (GDF-15): A Potential Biomarker and Therapeutic Target for Cancer-Associated Weight Loss

Oncology Letters
Cancer ResearchOncology
2016English

Interleukin-32: Its Role in Asthma and Potential as a Therapeutic Agent

Respiratory Research
PulmonaryRespiratory Medicine
2018English

A Novel Therapeutic Agent

Psychiatric Bulletin
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy